Gynecologic Cancer
Research conducted at Cleveland Clinic has updated our knowledge about gynecologic cancer
Published in Women's Health Weekly, November 26th, 2009
"Abraxane, a newer, Cremophor-free form of albumin bound paclitaxel has demonstrated an activity and an improved toxicity profile in breast and lung cancers. Five patients with gynecologic cancers (2 ovarian, 2 endometrial, and I cervical malignancy) received Abraxane after having a hypersensitivity reaction to paclitaxel. All five patients tolerated Abraxane well, experiencing no reactions or major side...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- American Cancer Society
Breast density associated with increased risk of cancer recurrence - Columbia University Medical Center
Drugs to treat anemia in cancer patients linked to thromboembolism - Faculty of 1000: Biology and Medicine
Faithful mothers have healthier babies - JAMA and Archives Journals
Persistent pain common for many women 2 to 3 years after breast cancer treatment - University of Wisconsin-Madison
FDA-approved drugs eliminate, prevent cervical cancer in mice - Weber Shandwick Worldwide
Fertility procedures need not delay breast cancer treatment for younger women - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
